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Abstract
Purpose: The aim of the study was to determine the
sonographic prevalence of benign focal liver lesions on
the basis of a population of hospital patients.
Methods: The ultrasound results in a population of
(n = 45,319) hospital patients over a period of 10 years
were examined retrospectively and evaluated for the
diagnosis of benign focal liver lesions [hepatic cysts,
hepatic hemangioma, focal nodular hyperplasia (FNH),
hepatic adenoma, and focal fatty sparing]. Results that
were incomplete or ambiguous were excluded from this
study.
Results: At least one of the lesions to be investigated was
diagnosed in 15.1% (n = 6839) of the patients of the
total population. The most commonly recorded lesion,
with a total prevalence of 6.3% (n = 2839), was focal
fatty sparing, followed by hepatic cysts with 5.8%
(n = 2631). The prevalence of hepatic hemangioma
was 3.3% (n = 1640), while that of FNH was 0.2%
(n = 81) and that of hepatic adenoma was 0.04%
(n = 19). An association between the occurrence of
benign focal liver lesions and age was observed.
Conclusions: The calculated prevalence of benign focal
liver lesions shows that on the fortuitous discovery of
space-occupying lesions of the liver, first consideration
should be given to focal fatty sparing, simple hepatic
cysts and hemangiomas. The finding of a FNH or an
adenoma is rarely a random discovery.
Key words: Focal liver lesions—Hepatic cysts—Hepatic
hemangioma—Focal nodular hyperplasia—Hepatic
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Abdominal ultrasound, particularly of the liver, is a
widely available, inexpensive technique that can be ra-
pidly performed without exposing the patient to radia-
tion. It is therefore the method of choice in primary
diagnostic investigations in most specialist areas of
medicine, but especially for imaging the abdomen [1].
Due to the continuously improving technical standard of
ultrasound equipment and the high number of abdomi-
nal ultrasound examinations, the number of—often for-
tuitously—discovered focal liver lesions, the so-called
‘‘incidentalomas,’’ is also increasing markedly [2]. The
investigating physician is therefore increasingly faced
with the problem of differentiating between malignant
and benign space-occupying processes and of distin-
guishing the various lesions from each other [2–4]. It is
important for the subsequent diagnosis and therapy and
the associated expended time and effort of the treating
physician and the affected patient—to say nothing of the
related costs—that the focus visible on ultrasound is
classified as reliably as possible [4]. Besides the clinical
parameters and the patient’s medical history, the quality
of the ultrasound equipment used and the investigator’s
experience also play a significant role. 57% of all liver
lesions found by ultrasound are benign [5]. Therefore, a
fundamental knowledge of the prevalence and image
morphology of hepatic hemangiomas, hepatic cysts, fo-
cal nodular hyperplasia (FNH), hepatic adenoma, and
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focal fatty sparing is essential. The number of recent
ultrasound studies on the prevalence of benign liver le-
sions is relatively limited. In the past 10 years, compar-
atively few ultrasound-based studies have appeared on
this subject [6–9]. Comparison of the study results is also
difficult, because the studies differ with regard to the
selection of the population investigated, the number of
individuals investigated, and the diagnostic method used
[ultrasound (US), computed tomography (CT), magnetic
resonance imaging (MRI) or autopsy]. This is also ulti-
mately reflected in the prevalence rates determined in the
respective studies. Published values for the prevalence of
hepatic hemangiomas range from 0.1% to 20.0% [6, 7, 10,
11] and those for hepatic cysts from 0.06% to 17.8% [7, 9,
10]. Only a few studies have determined the prevalence of
FNH, hepatic adenoma and focal fatty sparing. The
prevalence of FNH lies between 0.8% and 3.2% [12–15],
of hepatic adenoma from 0.4% to 1.5% [11, 12, 15, 16],
and of focal fatty sparing between 7.2% and 19.8% [8, 17,
18]. Several studies on the prevalence of focal liver le-
sions are primarily concerned with just one individual
type of lesion or they investigate the prevalence for a
given pre-existing disease [11, 19–21]. In addition, many
studies on the prevalence of benign space-occupying le-
sions of the liver were conducted in the 1990’s or earlier,
i.e., at a time when the image quality of the ultrasound
devices used was greatly inferior [17, 21–23]. Without
continually carrying out new studies at regular intervals,
no comparative statements concerning possible changes
in the prevalence of benign focal liver lesions over time
are possible.
The aim of this study was to evaluate the prevalence
of hepatic hemangioma, FNH, hepatic cysts, focal fatty
sparing, and hepatic adenoma in a large population of
university hospital patients and to compare this with the
values published in the literature.
Methods
Data of 45,319 patients (48.5% women and 51.48% men)
were analyzed using a PC-based, standardized docu-
mentation system (ViewPoint GE Healthcare GmbH
Wessling/Oberpfaffenhofen, Germany). Patients had
consecutively presented from January 2003 to November
2013 and had undergone abdominal ultrasound for a
variety of diseases or for preventive medical examination
in the university hospital. Inclusion criterion for this
analysis was a positive sonographic diagnosis of benign
focal liver lesions (hepatic cysts, hepatic hemangioma,
FNH, hepatic adenoma and focal fatty sparing; Figs. 1,
2, 3 4 and 5). Results with inadequate or incomprehen-
sible written or visual documentation of the finding were
excluded from the study. Patients with polycystic liver
diseases were excluded from this study. Ultrasound re-
sults typical of adenomas and FNH were only included
in the evaluation, if these had been confirmed by further
imaging or histology. The diagnosis of FNH was con-
firmed primarily by CEUS. At further existing unclarity,
an MRI was performed in unclear findings at MRI
puncture of the lesions were attempted.
All ultrasonographic examinations were performed in
the ultrasound unit by experienced physicians. Exami-
Fig. 1. Focal fatty sparing.
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nations were performed using following devices: Philips
HDI 3000, HDI 5000, IU22, Toshiba Aplio 500, and
Siemens Acuson S3000. The used probes are C2-5, C1-5,
and C1-6 (1–6 MHz). All lesions were examined also by
color and power Doppler ultrasound. The liver was
examined in inter- and/or subcostal planes with a fan-like
motion allowing assessment of both the hepatic par-
enchyma and the intrahepatic bile ducts.
Following parameters were recorded and evaluated
on the basis of the above-mentioned research question:
positive/negative ﬁnding, nature of tumor, age and gen-
der of the patient, number of foci (solitary, multiple), the
respective ultrasound characteristics of the focus and size
of the tumor (maximum diameter). The number of focal
lesions was considered separately up to a ﬁgure of ﬁve
lesions. From six or more foci upwards, these were
Fig. 2. Cyst.
Fig. 3. Hemangioma.
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combined as ‘‘more than ﬁve lesions.’’ The information
about lesion size was based on the maximum measurable
diameter in each case. If no unequivocal and/or accept-
able statements about the above-mentioned parameters
could be made from the re-inspected ultrasound images,
these were expanded and/or measured again. Used cri-
teria for the diagnosis of the lesions are presented in
Table 1.
The study was conducted in accordance with the
Guidelines of the Declaration of Helsinki and the rec-
ommendations of Good Clinical Practice. The project
received a positive opinion from the local ethics com-
mittee (No. 377/13).
The statistical calculations were carried out using the
statistics software SAS 9.2 (SAS Institute Inc., Cary,
North Carolina, USA) and the data evaluated using
descriptive statistics. For continuous variables, the mean
and standard deviation were calculated, while categorical
attributes were presented in absolute and relative fre-
quencies. In order to demonstrate differences between
patients with and without a lesion, the Wilcoxon signed
rank-sum test was applied for continuous variables and
Fig. 4. Focal nodular
hyperplasia.
Fig. 5. Adenoma.
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the v2 test for categorical variables, unless the sample size
was too small, in which case Fisher’s exact test was used.
The level of significance was set at a = 5%, and the p
value was given to four decimal places.
Results
Between 01/2003 and 11/2013, the liver was examined by
ultrasound in a total of 45,319 patients, of whom 48.5%
were women (n = 21,988) and 51.48% men
(n = 23 331). The mean age of patients at the time of the
investigation was 56 ± 18.1 years (range: 4 months–
105 years). On average, women were aged
56.1 ± 18.8 years and men 55.9 ± 17.4 years. At least
one of the lesions of interest was found in a total of 6851
patients (15.1% of the population examined). A total of
44.9% of these patients were outpatients and 55.1%
inpatients. The most common lesion was focal fatty
sparing, which was diagnosed in 2839 cases, corre-
sponding to a prevalence of 6.3%. It was most often
found in the 51–60 years age group; the mean age of the
patients with focal fatty sparing was 54.9 ± 14.5 years.
Age-specific prevalence was far less apparent in the
younger age groups and in the elderly. Men were affected
much more often (63.5%) than women (36.5%). The
mean maximum measured size of the focal fatty sparing
was 20.6 mm. All the cases of focal fatty sparing that we
encountered were solitary findings in its typical location
in liver segment IV in the region of the gallbladder bed.
The age-dependent frequency of hepatic steatosis and the
related prevalence of focal fatty sparing in patients with
hepatic steatosis were also determined (Table 2). The
frequency of focal fatty sparing in patients with hepatic
steatosis decreased with age and in the youngest age
group of patients with hepatic steatosis, namely under
30 years of age, the specific prevalence of focal fatty
sparing was over 90%. In our study, this figure fell al-
most linearly with increasing age and amounted to only
66.8% in the group of patients over 70 years of age.
The second most commonly diagnosed liver lesion
was the hepatic cyst, with 5.8% (n = 2631). Hepatic
cysts became more common with age. The youngest
patient group, under 30 years of age, was scarcely af-
fected, with an age-specific prevalence of 0.8% (n = 21).
Most hepatic cysts were found in the oldest patients, with
a frequency of 38.5% (n = 1012). The mean age was
64.7 years. Women were somewhat more affected
(56.1%, n = 1477) than men (43.9%, n = 1154). The
largest measured cyst diameter averaged 22.3 mm. Soli-
tary cysts were found in 62.8% (n = 1652) of cases.
In our patient population, the prevalence of hepatic
hemangioma was 3.6% (n = 1640). As regards the age
distribution, the respective age-specific prevalence began
with 7.0% (n = 115) in the youngest patients and rose to
a maximum of 22.5% (n = 369) of all discovered
hemangiomas in the age group between 51 and 60 years.
Lower prevalence was again determined in the highest
age groups. The gender distribution of hemangioma was
almost balanced, with 53.4% (n = 879) women/46.6%
(n = 761) men. 76.67% (n = 1157) of diagnosed
hemangiomas were solitary, and the average size of the
hemangiomas was 20.1 mm.
The prevalence of FNH was 0.2% (n = 81). The
highest prevalence was found in younger women, and
86.4% (n = 70) of all patients with FNH were females.
The peak age for FNH occurred in the youngest patient
group with 34.6% (n = 28) of the diagnosed lesions and
fell continuously with increasing age. Multiple FNHs
were rare; the prevalence of solitary FNHs was 88.9%
(n = 72), and the average size was 51.6 mm.
With only 19 cases and hence a prevalence of 0.04%,
hepatic adenoma was the rarest of the liver lesions we
investigated. Overall, more adenomas were diagnosed in
the younger patient groups under 50 years of age than in
the older ones. In our population, a maximum occurred
Table 1. Criteria Used to Diagnose Each Lesion Type
Liver lesion Criteria
Focal fatty sparing Localization
Adjacent to the porta
hepatis (segment IV)
Gallbladder fossa







Round or oval form






FNH Spoke-wheel distribution in
Doppler and Power-Doppler














<30 164 154 93.90
31–40 298 272 91.28
41–50 629 545 86.64
51–60 899 718 79.87
61–70 920 685 74.46
>70 696 465 66.81
Gender
Male 2165 1802 83.23
Female 1441 1037 71.96
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at between 41 and 50 years of age. 84.2% (n = 16) of
patients with adenoma were women. Apart from 2
exceptions, all diagnosed adenomas were solitary find-
ings (89.5%, n = 17). The mean size was 39.0 mm (Ta-
ble 3).
Discussion
Studies concerning the prevalence of benign focal liver
lesions present a quite heterogeneous picture as regards
the precise research question posed, the size of the pop-
ulation studied, and the investigative methods used. It is
therefore difﬁcult to compare the various study results
and apply them to routine ultrasound primary diagnos-
tics. For example, the prevalence of hepatic hemangioma
determined in the studies ranged from 0.1% to 20.0% and
that of hepatic cysts from 0.06% to 17.8%. Only a very
few studies investigated the prevalence of FNH, hepatic
adenoma, and focal fatty sparing. The prevalence ﬁg-
ures reported in previous ultrasound studies for FNH
were 0.8%–3.2% and for hepatic adenoma 0.4%–1.5% [8,
15, 17, 20].
Liver areas with reduced focal, rarely zonal accumu-
lation of fat can occur in hepatic steatosis. The most
common site of these pseudo lesions are hepatic segments
IV and V, the gallbladder bed, the falciform ligament
region, and ventral to the portal vein. In rare cases, focal
fatty sparing has also been described in other liver seg-
ments where, in the ﬁrst instance, it is generally difﬁcult
to distinguish from malignant lesions and can hence pose
considerable problems for a differential diagnosis [24–
26]. To date, only a few studies have been published on
the prevalence of focal fatty sparing or of focal fat dis-
tribution disorders in the liver [8, 27]. Kratzer et al.
calculated a value of 9.05% in a random population
collective [8]. The research group of Koseoglu reported a
prevalence of focal fatty sparing of up to 19.8 [18] Strunk
et al. reported a prevalence of 7.2% in a population of
patients with colorectal carcinoma [17]. Our result of
6.3% is below the prevalence figures of Kratzer et al. and
Strunk et al. [8, 17]. The size and age structure of the
respective study populations, as well as the quality of the
ultrasound equipment used, need to be considered here.
As also found by Aubin et al., one possible cause could
be the lower clustering of focal fatty sparing in patients
with status post cholecystectomy, whose number in-
creases with age and occurs more frequently in a hospital
population than in a random sample of the entire pop-
ulation [24].
Considerably more studies have investigated the
prevalence of hepatic hemangioma than of focal fatty
sparing, FNH, and adenoma [6, 7, 9, 11, 21]. The
majority of the more recent ultrasound-based prevalence
studies show significantly higher prevalence figures than
older ultrasound-based studies (Table 4). Our prevalence
figure of 3.6% for hemangioma lies in the mid-range
compared to the previously published results from
ultrasound-based studies [6, 7, 9, 17]. In comparison with
CT, MRI, and autopsy studies, which show a far higher
range of prevalence, our figure is in the lower third [10,
11, 19, 20]. The highest prevalence figures were reported
from autopsy and CT studies [12, 15, 19, 28]. In terms of
the age distribution and average size, our results corre-
spond to those of comparable studies [13, 19]. Gandolfi
et al. described a higher prevalence of hemangioma in
middle aged or older patients, while Rungsinaporn et al.
reported a higher prevalence of hepatic hemangioma in
women—resulting that we were unable to corroborate
with our data (Table 3) [21, 29].
Table 3. Results on the Prevalence and Epidemiological Distribution of Benign Liver Lesions
Focal fatty sparing Hemangioma Cyst FNH Adenoma
N (%)
Mean ± SD
Number 2839 (6.26%) 1640 (3.62%) 2631 (5.81%) 81 (0.18%) 19 (0.04%)
Age (years) 54.87 ± 14.53 52.61 ± 15.10 64.70 ± 13.03 37.83 ± 14.20 40.68 ± 11.60
Age groups
<30 154 (5.42%) 115 (7.01%) 21 (0.80%) 28 (34.57%) 4 (21.05%)
31–40 272 (9.58%) 226 (13.78%) 62 (2.36%) 24 (29.63%) 4 (21.05%)
41–50 545 (19.20%) 355 (21.65%) 255 (9.69%) 15 (18.52%) 7 (36.84%)
51–60 718 (25.29%) 369 (22.50%) 534 (20.30%) 7 (8.64%) 2 (10.53%)
61–70 685 (24.13%) 323 (19.70%) 747 (28.39%) 3 (3.70%) 2 10.53%)
>70 465 (16.38%) 252 (15.37%) 1012 (38.46%) 4 (4.94%) –
Gender
Male 1802 (63.47%) 761 (46.40%) 1154 (43.86%) 11 (13.58%) 3 (15.79%)
Female 1037 (36.53%) 879 (53.60%) 1477 (56.14%) 70 (86.42%) 16 (84.21%)
Number of lesions
1 2839 (100%) 1157 (76.67%) 1652 (62.79%) 72 (88.89%) 17 (89.47%)
2 – 219 (14.51%) 419 (15.93%) 4 (4.94%) 2 (10.53%)
3 – 72 (4.77%) 198 (7.53%) 3 (3.70%) –
4 – 21 (1.39%) 111 (4.22%) 1 (1.23%) –
5 – 16 (1.06%) 44 (1.67%) 1 (1.23%) –
>5 – 24 (1.59%) 207 (7.87%) – –
Size (mm) 20.56 ± 10.23 20.06 ± 15.05 22.28 ± 19.06 51.63 ± 29.47 38.95 ± 27.47
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As with hemangioma, there are a comparatively large
number of prevalence studies for hepatic cysts, but they
also differ in terms of study size, patient populations
investigated, and diagnostic techniques used. Retro-
spective and prospective studies based on ultrasound
have reported prevalence data for hepatic cysts of be-
tween 0.1% and 11.3% [7, 9, 23, 29]. With our determined
prevalence of 5.8%, we are also here in the mid-range. In
the case of hepatic cysts, the range of prevalence fig-
ures from CT, MRI, or autopsy studies is also much
wider than that of the ultrasound-based studies [5, 10, 15,
19, 30]. In relation to the CT, MRI, and autopsy studies,
our prevalence is in the mid to lower third of the range.
CT-supported studies have reported the highest fig-
ures for prevalence [15, 19]. In line with our results, all
studies reported a higher prevalence of hepatic cysts with
increasing age [19, 22, 23, 30]. Most studies have also
found a gender-dependent aspect, with higher prevalence
figures for hepatic cysts in women [22, 23, 29, 30]. Our
measured mean cyst size of 2.2 cm corresponds to the
values published in the literature [19, 22, 23, 30].
There are only a few studies on the prevalence of
FNH [12–15]. The prevalence figures of the two ultra-
sound-based studies for FNH were 0.8% and 1.8% and
lie below the figures of between 1.8% and 3.2% reported
from CT, MRI, or pathological investigations [12–15].
Our figure of 0.18% is markedly lower than the data
published to date. This difference can be related to the
population size and age of the patients studied [13, 14].
Through higher performance ultrasound equipment and
the introduction of contrast-enhanced ultrasound, the
diagnosis of FNH can nowadays be made with higher
sensitivity and specificity [31].
There are no ultrasound studies on the prevalence of
hepatic adenoma within a large patient population.
Furthermore, there are only a few prevalence studies
based on CT, MRI investigations, and autopsy studies
[11, 12, 15, 16]. The prevalence data published so far on
hepatic adenoma are between 0.4% and 1.7%. The
understanding of hepatic adenoma has changed funda-
mentally in recent years [32, 33]. Through the division
into four different genotypic subtypes, new aspects have
emerged concerning prevalence and clinical presentation.
Naturally, these cannot be recorded in retrospective
ultrasound prevalence studies. The prevalence of 0.04%
determined by us is considerably lower than that found
in the previous studies. As was already put forward as a
possible explanation in the case of FNH, this could be
due to the age of the study participants, the size of the
patient population investigated, and the improved dif-
ferentiation possibilities of modern ultrasound equip-
ment. Unfortunately, we cannot compare our results on
age and gender distribution or those concerning the
average size of the hepatic adenoma with any of the
studies available to us. However, the occurrence of a
hepatic adenoma is associated with the ingestion of oral
contraceptives, which may be reflected in our results,
since we found the majority of adenomas in women aged
below 50 years [34].
Conclusions
In summary, our results show that the ﬁrst possibility to
be considered on the incidental discovery of space-oc-
cupying lesions of the liver—especially if hepatic steato-
sis is present—is focal fatty sparing. Simple hepatic cysts
and hemangiomas are the most common focal liver le-
sions. The ﬁnding of a FNH or an adenoma is rarely a
fortuitous result.
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